Home LiteratureArticle Details
PMID: 2837826 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Intracellular injection of cAMP induces a long-term reduction of neuronal K+ currents.

Science (New York, N.Y.) ·Vol. 240 ·No. 4859 ·1988-06-17 ·Pages 1664-6

Scholz KP, Byrne JH

Abstract

Intracellular signals that trigger long-term (24-hour) changes in membrane currents in identified neurons of Aplysia have been examined in order to understand the cellular mechanisms underlying long-term sensitization. Adenosine 3',5'-monophosphate (cAMP) was directly injected into individual sensory neurons to mimic the effects of sensitization training at the single cell level. Potassium currents of these cells were reduced 24 hours after injection of cAMP; these currents were similar to those reduced 24 hours after behavioral sensitization. These results suggest that cAMP is part of the intracellular signal that induces long-term sensitization in Aplysia.

MeSH Terms
Adenosine Monophosphate/pharmacology Animals Aplysia/physiology Cell Membrane/physiology Cyclic AMP/pharmacology Electric Conductivity Membrane Potentials/drug effects Neurons/drug effects,physiology Potassium/metabolism
Chemicals
Adenosine Monophosphate Cyclic AMP Potassium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Scholz K P
Department of Neurobiology and Anatomy, University of Texas Medical School, Houston 77225.
Byrne J H
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1988-06-17
Pages
1664-6
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Grants
NIMH NIH HHS · K02 MH00649 · United States
NINDS NIH HHS · NS 19895 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com